Facilities for the treatment of adults with haematological malignancies – 'Levels of Care': BCSH Haemato-Oncology Task Force 2009

By Matthey F.   Parker A.   Rule S. A. J.   Wimperis J. Z.   Ardeshna K. M.   Bird J. M.   Cullis J.   Lyttelton M. P. A.   McMillan A.   Jackson G. H.  

Hematology, Vol. 15, Iss. 2, 2010-04 ,pp. : 63-69

Maney Publishing

Access to resources Recommend Favorite

Reduced-Intensity Transplantation in the Treatment of Haematological Malignancies: Current Status and Future-Prospects

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 2, 2007-05 ,pp. : 163-188

Bentham Science Publishers

Access to resources Recommend Favorite

Do all patients with haematological malignancies need prophylactic platelets? No

By  

ISBT SCIENCE SERIES, Vol. 11, Iss. S1, 2016-01 ,pp. : 178-181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomics of MDR1/ABCB1 Gene: the Influence on Risk and Clinical Outcome of Haematological Malignancies

By Jamroziak Krzysztof   Robak Tadeusz  

Hematology, Vol. 9, Iss. 2, 2004-04 ,pp. : 91-105

Maney Publishing

Access to resources Recommend Favorite

A prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (auto PBSC&unknown;) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies

By Green R.H.A.   Watson D.   Buchanan S.   Morrison A.E.  

Transfusion and Apheresis Science, Vol. 24, Iss. 1, 2001-02 ,pp. : 85-90

Elsevier

Access to resources Recommend Favorite